AFJKNasdaqBlank ChecksFiscal year ends December 31Also trades as AFJKR, AFJKU

Aimei Health Technology Co., Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$12.27−0.00 (-0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Aimei Health Technology Co., Ltd. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Cash & Equivalents	0.00	0.03	0.58
Cash & Short-Term Investments	0.00	0.03	0.58
Prepaid Expenses & Other	–	0.00	–
Total Current Assets	0.00	0.03	0.58
Total Assets	12	74	70
Accrued Expenses	0.45	0.30	0.02
Other Current Liabilities	0.90	0.29	–
Total Current Liabilities	3.37	0.82	0.02
Total Liabilities	4.06	1.51	0.71
Common Stock	0.00	0.00	0.00
Retained Earnings	-4.06	-1.48	-0.13
Shareholders' Equity	-4.06	-1.48	-0.13
Total Equity	-4.06	-1.48	-0.13
Total Liabilities & Equity	12	74	70
Shares Outstanding(shares)	2.13	2.13	2.13

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -38.3%

Financial strength

Current ratio: 0.01
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –